BTK and PI3K Inhibitors Reveal Synergistic Inhibitory Anti-Tumoral Effects in Canine Diffuse Large B-Cell Lymphoma Cells

Bruton’s tyrosine kinase (BTK) and phosphoinositide 3-kinase (PI3K) in the B-cell receptor (BCR) signaling pathway are considered potential therapeutic targets for the treatment of B-cell lymphomas, among which, diffuse large B-cell lymphoma (DLBCL) is the most common type. Herein, we comparatively...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Weibo, Sender, Sina, Taher, Leila, Villa-Perez, Simon, Ma, Yixuan, Sekora, Anett, Ruetgen, Barbara C., Brenig, Bertram, Beck, Julia, Schuetz, Ekkehard, Junghanss, Christian, Nolte, Ingo, Murua Escobar, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658042/
https://www.ncbi.nlm.nih.gov/pubmed/34884478
http://dx.doi.org/10.3390/ijms222312673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658042/
https://www.ncbi.nlm.nih.gov/pubmed/34884478
http://dx.doi.org/10.3390/ijms222312673

Ejemplares similares